Cargando…

Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial

BACKGROUND: Patients with systemic lupus erythematosus (SLE) have substantial unmet medical need. Baricitinib is a Janus kinase (JAK)1 and 2 inhibitor that was shown to have therapeutic benefit in patients with SLE in a phase II clinical trial. The purpose of this study was to evaluate the median ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dörner, Thomas, van Vollenhoven, Ronald F., Doria, Andrea, Jia, Bochao, Ross Terres, Jorge A., Silk, Maria E., de Bono, Stephanie, Fischer, Peter, Wallace, Daniel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109322/ https://www.ncbi.nlm.nih.gov/pubmed/35578304 http://dx.doi.org/10.1186/s13075-022-02794-x

Ejemplares similares

Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus
por: Infantino, Maria, et al.
Publicado: (2021)

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2022)

Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in Addition to IgG Anti-dsDNA Help to Identify Glomerulonephritis and Active Disease
por: Villalta, Danilo, et al.
Publicado: (2013)

Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus
por: Fu, Shu Man, et al.
Publicado: (2015)

Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus
por: Biesen, Robert, et al.
Publicado: (2011)

Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus
por: Lyu, Mi-Ae, et al.
Publicado: (2023)

Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis
por: Morand, Eric, et al.
Publicado: (2023)

Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosus
por: Damoiseaux, Jan, et al.
Publicado: (2023)

The Effects of Flexibility on dsDNA–dsDNA Interactions
por: Chen, Chuanying, et al.
Publicado: (2022)

Differential DNA methylation associated with anti-dsDNA autoantibody production in systemic lupus erythematosus
por: Chung, SA, et al.
Publicado: (2012)

Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production
por: Chung, Sharon A., et al.
Publicado: (2011)

Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus
por: Mahler, Michael, et al.
Publicado: (2007)

Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort
por: Fabrizio, Conti, et al.
Publicado: (2015)

B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
por: Hedenstedt, Anna, et al.
Publicado: (2023)

High Avidity dsDNA Autoantibodies in Brazilian Women with Systemic Lupus Erythematosus: Correlation with Active Disease and Renal Dysfunction
por: Oliveira, Rodrigo C., et al.
Publicado: (2015)

Brief report on the relation between complement C3a and anti dsDNA antibody in systemic lupus erythematosus
por: Cai, Yao-Hua, et al.
Publicado: (2022)

The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
por: Rekvig, Ole Petter
Publicado: (2019)

CCR6(+) Th cell distribution differentiates systemic lupus erythematosus patients based on anti-dsDNA antibody status
por: Zhong, Wei, et al.
Publicado: (2018)

Comparisons of Anti-dsDNA Antibody Detection Methods by Chemiluminescent Immunoassay and Enzyme-Linked Immunosorbent Assay in Systemic Lupus Erythematosus
por: Chang, Huang-Chen, et al.
Publicado: (2021)

Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients
por: Han, Jing, et al.
Publicado: (2022)

Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus
por: Gomez-Bañuelos, Eduardo, et al.
Publicado: (2023)

Viral nanomotors for packaging of dsDNA and dsRNA
por: Guo, Peixuan, et al.
Publicado: (2007)

Mechanisms of Kidney Injury in Lupus Nephritis – the Role of Anti-dsDNA Antibodies
por: Yung, Susan, et al.
Publicado: (2015)

Peptide mimetics of anti-dsDNA idiotypes as a tool for lupus-specific IVIG preparation: specificity and efficacy in the treatment of experimental systemic lupus erythematosus
por: Blank, M, et al.
Publicado: (2005)

Changes in the tension in dsDNA alter the conformation of RecA bound to dsDNA–RecA filaments
por: Conover, Alyson J., et al.
Publicado: (2011)

Force spectroscopy and fluorescence microscopy of dsDNA–YOYO-1 complexes: implications for the structure of dsDNA in the overstretching region
por: Murade, Chandrashekhar U., et al.
Publicado: (2010)

Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides—As Antigens for Th Cells
por: Aas-Hanssen, Kristin, et al.
Publicado: (2015)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
por: Sohrabian, Azita, et al.
Publicado: (2019)

Anti‐dsDNA, anti‐nucleosome, anti‐C1q, and anti‐histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
por: Shang, Xiaoying, et al.
Publicado: (2021)

Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways
por: Dörner, Thomas, et al.
Publicado: (2020)

Protein chainmail variants in dsDNA viruses
por: Zhou, Z. Hong, et al.
Publicado: (2015)

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
por: Infantino, Maria, et al.
Publicado: (2015)

Sequential action of ATPase, ATP, ADP, Pi and dsDNA in procapsid-free system to enlighten mechanism in viral dsDNA packaging
por: Schwartz, Chad, et al.
Publicado: (2012)

Torque-limited RecA polymerization on dsDNA
por: van der Heijden, Thijn, et al.
Publicado: (2005)

Torque-limited RecA polymerization on dsDNA
por: van der Heijden, Thijn, et al.
Publicado: (2005)

Structure and Dynamics of dsDNA in Cell-like Environments
por: Singh, Amar, et al.
Publicado: (2022)

Severity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome: A cross-sectional analysis
por: Chen, Alexander, et al.
Publicado: (2016)

Early diagnosis of systemic lupus erythmatosus using ANN models of dsDNA binding antibody sequence data
por: Bahari, Mohamad Hasan, et al.
Publicado: (2010)

Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages
por: Zhang, Hui, et al.
Publicado: (2016)

Helicobacter pylori Infection Increased Anti-dsDNA and Enhanced Lupus Severity in Symptomatic FcγRIIb-Deficient Lupus Mice
por: Surawut, Saowapha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_62hlatls1tsee8ok55hdmm6kbk